PIK3CA and endometrial cancer: Indeed, PI3K signalling by either PIK3CA or PTEN mutations occurs in 40% of endometrial cancers but in <5% of ovarian cancers (Tashiro et al, 1997; Oda et al, 2005; Kolasa et al, 2006; Nakayama et al, 2006).